Exhale

The official blog of the Lung Institute.

Pittsburgh Lung Institute Grand Opening

13 Jul 2015
| Under Press | Posted by | 1 Comment
Pittsburgh Lung Institute Grand Opening

Lung Institute to Celebrate New Expansion with Ribbon Cutting Ceremony

Pittsburgh, PA (July 13, 2015) – The Lung Institute is opening its fourth clinic today, July 13, 2015. They will kick off opening the Pittsburgh clinic with a ribbon cutting celebration at noon, followed by light refreshments at their new location. The Lung Institute welcomes the new Pittsburgh-based staff, and is excited to provide new jobs in the area along with alternative treatment options for those who suffer from debilitating lung disease in the surrounding area.

The city of Pittsburgh is on the forefront of researching lung disease with programs like those at the Simmons Center for Interstitial Lung Disease at the University of Pittsburgh. The Lung Institute treats interstitial lung disease and other serious lung disorders including chronic obstructive pulmonary disease (COPD), emphysema, chronic bronchitis, pulmonary fibrosis and black lung.

Lung disease is the third leading cause of death in the United States, and most traditional treatment options only treat the symptoms rather than the disease itself. Most people who have been diagnosed with lung disease are prescribed a bronchodilator and a daily medication to help clear the respiratory path and reduce coughing. The advent of stem cell therapy, however, can be a game changer for those with lung disease.

Stem cells are the body’s natural healing system, and are what causes something as simple as a cut, or as complex as a disease to heal itself. The Lung Institute uses very precise and safe technology in their state-of-the-art clinics to harvest stem cells from a patient’s own blood, fat or bone marrow, and then reintroduce them into the body, directing their healing ability to the lung tissue. This high dose of stem cells starts to promote healing and helps patient breathe easier. While there is no cure for lung disease, stem cell therapy at the Lung Institute reportedly improves the lives of over 70 percent of patients who receive treatment.

To date the Lung Institute has treated over 1,000 patients with stem cell therapy, and is excited to increase the number of improved lives with the addition of the Pittsburgh Clinic. Dr. Jack Coleman, Jr, MD, is the Medical Director for the Lung Institute in Pittsburgh. He earned his medical degree from the University of Cincinnati as well as completed his internship and general surgery residency at the institution. Dr. Coleman is a board certified in physician and ensures that all treatments and staff will follow strict standards with the highest excellence in personalized patient care.

“I am very excited about these new facilities opening,” says Dr. Coleman. “The Lung Institute is providing innovative procedures for patients with debilitating conditions and will be a prime location for patients in Pittsburgh.”

About the Lung Institute

At the Lung Institute, we help those with lung disease breathe easier through innovative regenerative medicine solutions. We understand the challenges that lung disease sufferers face when it comes to finding the best treatment option in order to obtain a better quality of life. With this in mind, we are committed to providing our patients with the best and most effective treatment options to bring their lives back within reach. For more information, visit our website at LungInstitute.com, like us on Facebook, Follow us on Twitter or call us today at (800) 729-3065.

Your Comment

Your email address will not be published.



* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.